DJDavid P. Jarmolowicz

David P. Jarmolowicz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David P. Jarmolowicz has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differential Probability Discounting Rates of Gamblers in an American Indian Population

    by Tadd D. Schneider, Jordyn A. Gunville, Vlad B. Papa, Morgan G. Brucks, Christine M. Daley, Laura E. Martin, David P. Jarmolowicz

    Probability discounting, a subset of behavioral economic research, has a rich history of investigating choice behavior, especially as it pertains to risky decision making. Gambling involves both choice behavior and risky decision making which makes it an ideal behavior to investigate with discounting tasks. With proximity to a casino being one of the biggest risk factors, studies into the American Indian population have been a neglected population of study. Using outcome measures from a pre-scan probability discounting task, the current study equated the scan task to evaluate behavioral and neurobiological differences in gamblers vs. non-gamblers. Gamblers showed differences in behavioral tasks (lower discounting rates) but not in patterns of neural activation.


  • Reinforcer pathology II: Reward magnitude, reward delay, and demand for alcohol collectively relate to college students' alcohol related problems

    by Stefanie S. Stancato, Tadd D. Schneider, Derek D. Reed, Shea M. Lemley, Ale Carrillo, David P. Jarmolowicz

    The reinforcer pathologies model of addiction posits that two characteristic patterns of operant behavior characterize addiction. Specifically, individuals suffering from addiction have elevated levels of behavioral economic demand for their substances of abuse and have an elevated tendency to devalue delayed rewards (reflected in high delay discounting rates). Prior research has demonstrated that these behavioral economic markers are significant predictors of many of college students' alcohol‐related problems. Delay discounting, however, is a complex behavioral performance likely undergirded by multiple behavioral processes. Emerging analytical approaches have isolated the role of participants' sensitivity to changes in reinforcer magnitude and changes in reinforcer delay. The current study uses these analytic approaches to compare participants' discounting of money versus alcohol, and to build regression models that leverage these new insights to predict a wider range of college students' alcohol related problems. Using these techniques, we were able to 1) demonstrate that individuals differed in their sensitivity to magnitudes of alcohol versus money, but not sensitivity to delays to those commodities and 2) that we could use our behavioral economic measures to predict a range of students' alcohol related problems.


  • On the discounting of cannabis and money: Sensitivity to magnitude vs. delay

    by David P. Jarmolowicz, Derek D. Reed, Stefanie S. Stancato, Shea M. Lemley, Michael J. Sofis, Andrew Fox, Laura E. Martin


  • Blunted satiety in fatty Zucker rats

    by David P. Jarmolowicz, Tadd D. Schneider, Ale Carrillo, Jennifer L. Hudnall, Stefanie S. Stancato


  • Open Access

    The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli

    by Sean C. Godar, Roberto Cadeddu, Gabriele Floris, Laura J. Mosher, Zhen Mi, David P. Jarmolowicz, Simona Scheggi, Alicia A. Walf, Carolyn J. Koonce, Cheryl A. Frye, et al.

    Finasteride (FIN) is the prototypical inhibitor of steroid 5α-reductase (5αR), the enzyme that catalyzes the rate-limiting step of the conversion of progesterone and testosterone into their main neuroactive metabolites. FIN is clinically approved for the treatment of benign prostatic hyperplasia and male baldness; while often well-tolerated, FIN has also been shown to cause or exacerbate psychological problems in vulnerable subjects. Evidence on the psychological effects of FIN, however, remains controversial, in view of inconsistent clinical reports. Here, we tested the effects of FIN in a battery of tests aimed at capturing complementary aspects of mood regulation and stress reactivity in rats. FIN reduced exploratory, incentive, prosocial, and risk-taking behavior; furthermore, it decreased stress coping, as revealed by increased immobility in the forced-swim test (FST). This last effect was also observed in female and orchiectomized male rats, suggesting that the mechanism of action of FIN does not primarily reflect changes in gonadal steroids. The effects of FIN on FST responses were associated with a dramatic decrease in corticotropin release hormone (CRH) mRNA and adrenocorticotropic hormone (ACTH) levels. These results suggest that FIN impairs stress reactivity and reduces behavioral activation and impulsive behavior by altering the function of the hypothalamus–pituitary–adrenal (HPA) axis.


  • On the behavioral economics of medication choice: A research story

    by David P. Jarmolowicz, Derek D. Reed, Amanda S. Bruce, Jared M. Bruce


  • Modeling effects of risk and social distance on vaccination choice

    by David P. Jarmolowicz, Derek D. Reed, Alex J. Francisco, Jared M. Bruce, Shea M. Lemley, Amanda S. Bruce

    Despite vaccines' consistently demonstrated effectiveness, vaccination rates remain suboptimal due to vaccine refusal. Low vaccination rates are particularly problematic for individuals who cannot be vaccinated for medical reasons and thus must rely on herd immunity (i.e., protection of vulnerable individuals due to the high rate of vaccination of other—often socially distant—individuals). The current study uses a novel decision‐making task to examine how three variables impacted participants' highest acceptable probability of side effects to their children: 1) the severity of the side effects their children experience, 2) the social distance to the beneficiary of the vaccination, and 3) the probability that the vaccine will prevent disease for that designated beneficiary. Participants' willingness to risk potential side effects of vaccination systematically decreased as the 1) effectiveness of the vaccination decreased, 2) the beneficiary of the vaccination became more socially distant, and 3) the severity of side effects increased. These data were well‐described by behavioral economic models used to examine the discounting of other health behavior.


  • Open Access

    Delay discounting as impaired valuation: Delayed rewards in an animal obesity model

    by David P. Jarmolowicz, Jennifer L. Hudnall, Luanne Hale, Stephen C. Fowler, Marco Bortolato, Shea M. Lemley, Michael J. Sofis

    Obesity is a major public health problem, which, like many forms of addiction, is associated with an elevated tendency to choose smaller immediate rather than larger delayed rewards, a response pattern often referred to as excessive delay discounting. Although some accounts of delay discounting conceptualize this process as impulsivity (placing the emphasis on overvaluing the smaller immediate reward), others have conceptualized delay discounting as an executive function (placing the emphasis on delayed rewards failing to retain their value). The present experiments used a popular animal model of obesity that has been shown to discount delayed rewards at elevated rates (i.e., obese Zucker rats) to test two predictions that conceptualize delay discounting as executive function. In the first experiment, acquisition of lever pressing with delayed rewards was compared in obese versus lean Zucker rats. Contrary to predictions based on delay discounting as executive function, obese Zucker rats learned to press the lever more quickly than controls. In the second experiment, progressive ratio breakpoints (a measure of reward efficacy) with delayed rewards were compared in obese versus lean Zucker rats. Contrary to the notion that obese rats fail to value delayed rewards, the obese Zucker rats' breakpoints were (at least) as high as those of the lean Zucker rats.


  • KU32 prevents 5-fluorouracil induced cognitive impairment

    by Michael J. Sofis, David P. Jarmolowicz, Sam V. Kaplan, Rachel C. Gehringer, Shea M. Lemley, Gaurav Garg, Brian S. Blagg, Michael A. Johnson